MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,426,000 | +44.5% | 302,120 | 0.0% | 0.23% | +59.9% |
| Q2 2022 | $3,755,000 | +44.4% | 302,120 | +54.8% | 0.14% | +77.5% |
| Q1 2022 | $2,600,000 | -14.4% | 195,211 | 0.0% | 0.08% | -5.9% |
| Q4 2021 | $3,039,000 | -30.6% | 195,211 | 0.0% | 0.08% | -30.9% |
| Q3 2021 | $4,381,000 | -1.4% | 195,211 | 0.0% | 0.12% | +19.4% |
| Q2 2021 | $4,445,000 | -3.6% | 195,211 | -12.9% | 0.10% | 0.0% |
| Q1 2021 | $4,612,000 | -25.5% | 224,083 | 0.0% | 0.10% | -27.5% |
| Q4 2020 | $6,189,000 | +75.0% | 224,083 | -11.0% | 0.14% | +63.2% |
| Q3 2020 | $3,536,000 | -43.8% | 251,639 | -17.6% | 0.09% | -39.6% |
| Q2 2020 | $6,294,000 | +144.7% | 305,230 | -10.4% | 0.14% | +121.5% |
| Q1 2020 | $2,572,000 | -37.6% | 340,644 | +28.4% | 0.06% | -20.7% |
| Q4 2019 | $4,119,000 | +163.5% | 265,381 | -11.7% | 0.08% | +134.3% |
| Q3 2019 | $1,563,000 | -27.6% | 300,616 | +26.1% | 0.04% | -31.4% |
| Q2 2019 | $2,158,000 | -38.3% | 238,398 | +62.7% | 0.05% | -37.8% |
| Q1 2019 | $3,498,000 | +45.4% | 146,552 | 0.0% | 0.08% | +1.2% |
| Q4 2018 | $2,405,000 | +26.8% | 146,552 | +105.3% | 0.08% | +50.0% |
| Q3 2018 | $1,896,000 | +52.9% | 71,400 | +31.7% | 0.05% | +86.2% |
| Q2 2018 | $1,240,000 | +7.6% | 54,200 | 0.0% | 0.03% | -9.4% |
| Q1 2018 | $1,152,000 | – | 54,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |